<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; MELA</title>
	<atom:link href="http://www.stockbloghub.com/tag/mela/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(AAPL) Company News for September 27, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/09/27/aapl-company-news-for-september-27-2011-corporate-summary/84142</link>
		<comments>http://www.stockbloghub.com/2011/09/27/aapl-company-news-for-september-27-2011-corporate-summary/84142#comments</comments>
		<pubDate>Tue, 27 Sep 2011 17:58:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Berkshire Hathaway]]></category>
		<category><![CDATA[BRKB]]></category>
		<category><![CDATA[CH Energy Group Inc]]></category>
		<category><![CDATA[CHG]]></category>
		<category><![CDATA[Eastman Kodak Company]]></category>
		<category><![CDATA[EK]]></category>
		<category><![CDATA[Electro-optical Sciences Inc]]></category>
		<category><![CDATA[Ivanhoe Mines Limited]]></category>
		<category><![CDATA[IVN]]></category>
		<category><![CDATA[MELA]]></category>
		<category><![CDATA[Odyssey Marine Exploration Inc]]></category>
		<category><![CDATA[OMEX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84142</guid>
		<description><![CDATA[•    Share prices of Buffet&#8217;s Berkshire Hathaway (NYSE:BRKB) closed 8.62% higher after the company said it might buy back stock for the first time since 1965 •    i-Phone maker Apple&#8217;s (NASDAQ:AAPL) shares fell marginally,  by 0.28% to close at $403.17 after the company said it may lower its production of iPads in the fourth quarter •    Share prices of Eastman Kodak (NYSE:EK) declined 26.89% after the seller of imaging products announced it has drawn $160 million from its credit line •    Medical device company MELA Sciences, Inc. (NASDAQ:MELA) said the FDA has approved its melanoma screening machine MelaFind. Following this development, shares of the company advanced 55.03% to close at $4.93 •    Power generation backup product maker Generac Holdings (NYSE:GNRC) projected that sales of residential flats will go up by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/27/aapl-company-news-for-september-27-2011-corporate-summary/84142/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(C) Company News for September 8, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/09/08/c-company-news-for-september-8-2011-corporate-summary/82796</link>
		<comments>http://www.stockbloghub.com/2011/09/08/c-company-news-for-september-8-2011-corporate-summary/82796#comments</comments>
		<pubDate>Thu, 08 Sep 2011 16:35:03 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Money Center Banks]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Chevron Corporation]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[CVX]]></category>
		<category><![CDATA[Electro-optical Sciences Inc]]></category>
		<category><![CDATA[FCEL]]></category>
		<category><![CDATA[FuelCell Energy Inc]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[GM]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[MELA]]></category>
		<category><![CDATA[NVDA]]></category>
		<category><![CDATA[NVIDIA Corporation]]></category>
		<category><![CDATA[VASCO Data Security International Inc]]></category>
		<category><![CDATA[VDSI]]></category>
		<category><![CDATA[Yahoo! Inc.]]></category>
		<category><![CDATA[YHOO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82796</guid>
		<description><![CDATA[•    Share prices of FuelCell Energy, Inc. (NASDAQ:FCEL) advanced 25.24% after the power plant maker&#8217;s sales figures came in above analysts&#8217; average estimates •    According to a report by Citi (NYSE:C) analysts, car sales of General Motors Co. (NYSE:GM) could increase to 13.9 million units by next year •    Shares of diagnostic device developer MELA Sciences, Inc. (NASDAQ:MELA) gained 56.25% to close at $3.50 after the European Union approved the company&#8217;s diagnostic device which will help to detect skin cancer •    Chip makers NVIDIA Corp. (NASDAQ:NVDA) said its sales were growing at a faster pace than anticipated. Following this announcement, shares of the company rose 8.12% to close at $14.25 •    Internet company Yahoo! Inc. (NASDAQ:YHOO) fired its CEO Carol Bartz and replaced her with company&#8217;s CFO Timothy Morse. According ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/08/c-company-news-for-september-8-2011-corporate-summary/82796/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MNKD) Why Phase II is the Sweet Spot for Biotech Investing</title>
		<link>http://www.stockbloghub.com/2011/04/13/mnkd-why-phase-ii-is-the-sweet-spot-for-biotech-investing/71385</link>
		<comments>http://www.stockbloghub.com/2011/04/13/mnkd-why-phase-ii-is-the-sweet-spot-for-biotech-investing/71385#comments</comments>
		<pubDate>Wed, 13 Apr 2011 16:23:10 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CEL-SCI Corporation]]></category>
		<category><![CDATA[CVM]]></category>
		<category><![CDATA[DCTH]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[Electro-optical Sciences Inc]]></category>
		<category><![CDATA[MannKind Corporation]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>
		<category><![CDATA[MELA]]></category>
		<category><![CDATA[MNKD]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71385</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Healthcare Expert Wednesday, April 13, 2011: Issue #1490 I recently received a call from an investor relations representative who wanted to know if I’d be interested in hearing about a small biotech company with a drug candidate in Phase II trials. Would Rory McIlroy have liked a do-over on Sunday at Augusta? Phase II trials are my favorite time to get involved in a biotech company. I’ll explain why in a moment. But first, a quick review of the phases of clinical trials… The Three Distinct Phases of Clinical Trials Before a new, experimental drug is tried in humans, it’s put to work in test tubes and then animals. Once it’s ready for human trials, it’s tested in three distinct phases. The Phase I trial ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/13/mnkd-why-phase-ii-is-the-sweet-spot-for-biotech-investing/71385/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MELA) How to Unearth Explosive Small-Cap HealthCare Stocks</title>
		<link>http://www.stockbloghub.com/2009/08/27/mela-how-to-unearth-explosive-small-cap-healthcare-stocks/13693</link>
		<comments>http://www.stockbloghub.com/2009/08/27/mela-how-to-unearth-explosive-small-cap-healthcare-stocks/13693#comments</comments>
		<pubDate>Fri, 28 Aug 2009 00:24:58 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[Electro-optical Sciences Inc]]></category>
		<category><![CDATA[MELA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13693</guid>
		<description><![CDATA[by Marc Lichtenfeld, Advisory Panelist How do I know if I’m doing a good job for my readers and subscribers? Simple. The stock market tells me every single day. I’m not someone who needs a pat on the back to feel good about my work.. However, even I’ll admit it’s nice to have my judgment validated – especially when it comes from a well-respected source like Barron’s. That’s what happened last Saturday when the 88-year publication published a story about the small-cap healthcare stock Electro-Optical Sciences (Nasdaq: MELA). As a result, shares soared 19% on Monday. What’s more, the author, Neil Martin, expects the stock to tack on an additional 50%, as the company’s melanoma detection device is expected to gain FDA approval and become a big hit with physicians ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/27/mela-how-to-unearth-explosive-small-cap-healthcare-stocks/13693/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

